首页 | 本学科首页   官方微博 | 高级检索  
     


Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era
Authors:Gi-Won Song  Sung-Gyu Lee  Shin Hwang  Ki-Hum Kim  Chul-Soo Ahn  Deok-Bog Moon  Tae-Yong Ha  Dong-Hwan Jung  Gil-Chun Park  Sung-Hwa Kang  Bo-Hyun Jung  Young-In Yoon  Nayoung Kim
Affiliation:1 Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Ulsan College of Medicine, Seoul, Republic of Korea;2 Asan Center for Life Science, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
Abstract:
Keywords:AMR, antibody-mediated rejection   ABOi, ABO-incompatible   ALDLT, adult living donor liver transplantation   RIT, rituximab   BS, biliary stricture   BD, bile duct   IA, isoagglutinin   CMV, cytomegalovirus   DIHBS, diffuse intrahepatic biliary stricture   LDLT, living donor liver transplantation   CNI, calcineurin inhibitor   ABOc, ABO-compatible   DSZ, desensitization   PE, plasma exchange   LGIT, local graft infusion therapy   CD20+, CD20 positive B lymphocyte   LFT, liver function test   CT, computed tomography   MELD, model for end-stage liver disease   ICU, intensive care unit   BMI, body mass index   IHM, in-hospital mortality   BPACR, biopsy-proven acute cellular rejection   ABOc, ABO compatible   GRWR, graft-to-recipient weight ratio   LT, liver transplantation   RL, right lobe   LL, left lobe   BDO, bile duct opening   BDA, bile duct anastomosis   DD, duct-to-duct   HJ, hepaticojejunostomy   AST, Aspartate transferase   ALT, alanine transferase
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号